These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 33139797)

  • 1. Novel Aza-podophyllotoxin derivative induces oxidative phosphorylation and cell death via AMPK activation in triple-negative breast cancer.
    Tailor D; Going CC; Resendez A; Kumar V; Nambiar DK; Li Y; Dheeraj A; LaGory EL; Ghoochani A; Birk AM; Stoyanova T; Ye J; Giaccia AJ; Le QT; Singh RP; Sledge GW; Pitteri SJ; Malhotra SV
    Br J Cancer; 2021 Feb; 124(3):604-615. PubMed ID: 33139797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of AMPK activation by N,N'-diarylurea FND-4b decreases growth and increases apoptosis in triple negative and estrogen-receptor positive breast cancers.
    Johnson J; Rychahou P; Sviripa VM; Weiss HL; Liu C; Watt DS; Evers BM
    PLoS One; 2019; 14(3):e0209392. PubMed ID: 30875375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FR58P1a; a new uncoupler of OXPHOS that inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway.
    Urra FA; Muñoz F; Córdova-Delgado M; Ramírez MP; Peña-Ahumada B; Rios M; Cruz P; Ahumada-Castro U; Bustos G; Silva-Pavez E; Pulgar R; Morales D; Varela D; Millas-Vargas JP; Retamal E; Ramírez-Rodríguez O; Pessoa-Mahana H; Pavani M; Ferreira J; Cárdenas C; Araya-Maturana R
    Sci Rep; 2018 Sep; 8(1):13190. PubMed ID: 30181620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoferlin regulates cellular lipid metabolism and promotes metastases in triple-negative breast cancer.
    Blomme A; Costanza B; de Tullio P; Thiry M; Van Simaeys G; Boutry S; Doumont G; Di Valentin E; Hirano T; Yokobori T; Gofflot S; Peulen O; Bellahcène A; Sherer F; Le Goff C; Cavalier E; Mouithys-Mickalad A; Jouret F; Cusumano PG; Lifrange E; Muller RN; Goldman S; Delvenne P; De Pauw E; Nishiyama M; Castronovo V; Turtoi A
    Oncogene; 2017 Apr; 36(15):2116-2130. PubMed ID: 27775075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligo-Fucoidan supplementation enhances the effect of Olaparib on preventing metastasis and recurrence of triple-negative breast cancer in mice.
    Chen LM; Yang PP; Al Haq AT; Hwang PA; Lai YC; Weng YS; Chen MA; Hsu HL
    J Biomed Sci; 2022 Sep; 29(1):70. PubMed ID: 36109724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming in triple-negative breast cancer.
    Wang Z; Jiang Q; Dong C
    Cancer Biol Med; 2020 Feb; 17(1):44-59. PubMed ID: 32296576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Jia D; Lu M; Jung KH; Park JH; Yu L; Onuchic JN; Kaipparettu BA; Levine H
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3909-3918. PubMed ID: 30733294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy stress-activated AMPK phosphorylates Snail1 and suppresses its stability and oncogenic function.
    Li M; Zhang L; Guan T; Huang L; Zhu Y; Wen Y; Ma X; Yang X; Wan R; Chen J; Zhang C; Wang F; Tang H; Liu T
    Cancer Lett; 2024 Jul; 595():216987. PubMed ID: 38815798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of AMPK and Akt in triple negative breast cancer lung colonization.
    Johnson J; Chow Z; Lee E; Weiss HL; Evers BM; Rychahou P
    Neoplasia; 2021 Apr; 23(4):429-438. PubMed ID: 33839456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway.
    Seto-Tetsuo F; Arioka M; Miura K; Inoue T; Igawa K; Tomooka K; Takahashi-Yanaga F; Sasaguri T
    Oncogene; 2021 Sep; 40(37):5579-5589. PubMed ID: 34304250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TQFL12, a novel synthetic derivative of TQ, inhibits triple-negative breast cancer metastasis and invasion through activating AMPK/ACC pathway.
    Wei C; Zou H; Xiao T; Liu X; Wang Q; Cheng J; Fu S; Peng J; Xie X; Fu J
    J Cell Mol Med; 2021 Nov; 25(21):10101-10110. PubMed ID: 34609056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Let-7a-5p inhibits triple-negative breast tumor growth and metastasis through GLUT12-mediated warburg effect.
    Shi Y; Zhang Y; Ran F; Liu J; Lin J; Hao X; Ding L; Ye Q
    Cancer Lett; 2020 Dec; 495():53-65. PubMed ID: 32946964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization.
    Hao W; Chang CP; Tsao CC; Xu J
    J Biol Chem; 2010 Apr; 285(17):12647-54. PubMed ID: 20110356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.
    Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1.
    Zhang R; Yang Y; Dong W; Lin M; He J; Zhang X; Tian T; Yang Y; Chen K; Lei QY; Zhang S; Xu Y; Lv L
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35181605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase: a potential therapeutic target for triple-negative breast cancer.
    Cao W; Li J; Hao Q; Vadgama JV; Wu Y
    Breast Cancer Res; 2019 Feb; 21(1):29. PubMed ID: 30791936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating EGFR-MYC-TXNIP axis: potential therapeutic implications.
    Iqbal MA; Chattopadhyay S; Siddiqui FA; Ur Rehman A; Siddiqui S; Prakasam G; Khan A; Sultana S; Bamezai RN
    FEBS J; 2021 Jan; 288(2):471-485. PubMed ID: 32356386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
    Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
    J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model.
    Almaguer G; Ortiz-Vilchis P; Cordero P; Martinez-Vega R; Perez-Durán J; Meaney E; Villarreal F; Ceballos G; Nájera N
    J Pharm Pharmacol; 2021 Dec; 73(12):1675-1682. PubMed ID: 34473289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.